Type 1 diabetes trials in Belgium
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Leuven
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Antwerpen, Bruxelles-Capitale, Jette, Leuven, Namur
- Age
- 1 year to 35 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Anderlecht, Edegem, Gent, Jette, Leuven, Liège, Namur, Sint-Lambrechts-Woluwe, Yvoir
- Age
- 1 year to 35 years
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - Phase 4Taking peopleAnti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
- Where
- Leuven
- Age
- Up to 17 years
- People
- 2,365 worldwide
- Run by
- Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 · EU 2023-507348-35-00 - Phase 3Taking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Brussels, Edegem, Jette, Leuven, Liège, Namur
- Age
- 1 year to 25 years
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - Phase 2Taking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Jette, Leuven, Liège
- Age
- 5 years to 40 years
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Alken, Kluisbergen, La Louviere, Mechelen, Roeselare, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - No phaseTaking peopleEvaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
- Where
- Antwerp, Brussels, Leuven
- Age
- 2 years and over
- People
- 116 worldwide
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07227805 - No phaseTaking peopleINNODIA Family & Friends Early-Stage T1D Detection Protocol
- Where
- Leuven
- Age
- 1 year to 45 years
- People
- 30,000 worldwide
- Run by
- INNODIA iVZW
See details and how to joinNCT07118098 - No phaseTaking peopleContinuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
- Where
- Antwerp, Bruges, Ghent, Jette, Leuven, Liège
- Age
- 5 years to 39 years
- People
- 75
- Run by
- Universitair Ziekenhuis Brussel
See details and how to joinNCT05777330 - No phaseEnrolling by invitationTo Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period
- Where
- Antwerp
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Sinocare
See details and how to joinNCT06904846 - No phaseTaking peopleA Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.
- Where
- Geel
- People
- 200
- Run by
- Sint Dimpna Ziekenhuis Geel
See details and how to joinNCT07297342 - Phase 4Taking peopleAnti-viral Action Against Type 1 Diabetes Autoimmunity
- Where
- Leuven
- Age
- 3 months to 4 months
- People
- 2,252 worldwide
- Run by
- Technical University of Munich
See details and how to joinNCT06452654 - No phaseTaking peoplePrevalence of NAFLD in T1DM Patients
- Where
- Genk
- Age
- 18 years and over
- People
- 138
- Run by
- Ziekenhuis Oost-Limburg
See details and how to joinNCT06445361 - No phaseTaking peopleLongitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
- Where
- Brussels
- Age
- 2 years to 30 years
- People
- 1,000
- Run by
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
See details and how to joinNCT06770621 - No phaseTaking peoplePrevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
- Where
- Leuven
- People
- 100,000
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05713448